SOT – 55th Annual Meeting and ToxExpo
This year’s meeting contains an exciting twist to our familiar program, as we will be featuring five talented and cutting-edge scientists through two plenary sessions, one each on Monday and Tuesday, and the Medical Research Council keynote on Wednesday. This new format allows you more access to emerging scientific knowledge. Our goal is to provide a forum for novel discoveries and approaches related to toxicology and to facilitate the advancement of toxicology by fostering the integration of toxicology with other biomedical disciplines. Through these endeavors we are working towards fulfilling our mission of creating a safer and healthier world by advancing the science and increasing the impact of toxicology.
Beyond this change, the program for our meeting at the Ernest N. Morial Convention Center in New Orleans contains all of the activities for which this premier event is known: more than 150 scientific sessions; thousands of abstract presentations; continuing education courses; approximately 350 ToxExpo exhibitors offering you the latest information on services and technology; awards presentations; receptions; career guidance and support; student activities; and more.
For further information, please visit – http://www.toxicology.org/events/am/AM2016/am.asp#
Dr. Klaus Weber, CEO of AnaPath GmbH, will present “Diagnostic Problems, Misinterpretations and other Pitfalls in the Evaluation of Medical Device Studies” at Room 211 on 14th March 2016 between 12:00 and 13:00 together with Eurofins BioPharma Product Testing Munich GmbH.
You are welcome to join us anytime at Booth 1410 for a piece of Swiss Chocolate or contact us for an appointment: firstname.lastname@example.org
Date(s) - 14/03/2016 - 17/03/2016